Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis

Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis

Hongchao Li,1 Wei He,2 Hongbo Lin,3 Angying Du,4 Xue Zhang,5 Han Yang,5 Shuli Qu5 1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, 211198, People’s Republic of China; 2Fertility and Reproductive Medicine Centre, The Southwest Hospital of AMU, Chongqing, 400...

Full description

Bibliographic Details
Main Authors: Li H, He W, Lin H, Du A, Zhang X, Yang H, Qu S
Format: Article
Language:English
Published: Dove Medical Press 2024-05-01
Series:Risk Management and Healthcare Policy
Subjects:
recombinant human follicle stimulating hormone
controlled ovarian stimulation
assisted reproductive technology
cost-effectiveness analysis.
Online Access:https://www.dovepress.com/recombinant-human-follicle-stimulating-hormone-in-controlled-ovarian-h-peer-reviewed-fulltext-article-RMHP

Internet

https://www.dovepress.com/recombinant-human-follicle-stimulating-hormone-in-controlled-ovarian-h-peer-reviewed-fulltext-article-RMHP

Similar Items